Saikosaponin D inhibits autophagosome‑lysosome fusion and induces autophagy‑independent apoptosis in MDA‑MB‑231 breast cancer cells

Fu,Ruoqiu; Zhang,Lin; Li,Yuanyuan; Li,Bin; Ming,Yue; Li,Zhiwei; Xing,Haiyan; Chen,Jianhong

doi:10.3892/mmr.2020.11155

Saikosaponin D inhibits autophagosome‑lysosome fusion and induces autophagy‑independent apoptosis in MDA‑MB‑231 breast cancer cells

Authors:
- Ruoqiu Fu
- Lin Zhang
- Yuanyuan Li
- Bin Li
- Yue Ming
- Zhiwei Li
- Haiyan Xing
- Jianhong Chen
View Affiliations

Affiliations: Department of Pharmacy, Daping Hospital, Army Medical University, Daping, Chongqing 400042, P.R. China
Published online on: May 18, 2020 https://doi.org/10.3892/mmr.2020.11155
Pages: 1026-1034
Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the effect of Saikosaponin D (SSD) and its underlying mechanism on apoptosis and autophagy in human breast cancer MDA‑MB‑231 cells. MTT assay, flow cytometry, western blotting and confocal fluorescence microscopy detection were employed. SSD, a kind of triterpenoid saponins extracted from Radix bupleuri, has been demonstrated to have the effects of anti‑inflammatory, antioxidative and anticancer effects and can regulate autophagy. The present study revealed that SSD induced apoptosis through the activation of the p38 mitogen‑activated protein kinase (MAPK) signaling pathway in human breast cancer MDA‑MB‑231 cells. The administration of SSD promoted the phosphorylation/activation of p38 MAPK in MDA‑MB‑231 cells, whereas pretreatment with SB203580, an effective p38 MAPK inhibitor, attenuated SSD‑mediated apoptosis, the cleavage of PARP and the activation of caspase‑3. In addition, SSD blocked autophagic degradation by inhibiting autolysosome formation, resulting in the accumulation of autophagosomes. Mechanistically, the results of the present study revealed that SSD inhibited the formation of autophagosomes by inhibiting autophagosome‑lysosome fusion, rather than by damaging lysosome function. Furthermore, blocking autophagy degradation was not associated with SSD‑mediated apoptosis. The genetic knockdown of autophagy‑related protein 5 markedly reduced SSD‑mediated LC3B‑II accumulation; however, it did not affect the SSD‑mediated phosphorylation/activation of p38, cleavage of PARP, activation of caspase‑3 or apoptosis. In conclusion, the findings of the present study suggest that SSD may induce apoptosis and block autophagic degradation, which provides further evidence of the association between the inhibition of autophagic degradation and cell death.

View Figures

View References

1	Yin Z, Pascual C and Klionsky DJ: Autophagy: Machinery and regulation. Microb Cell. 3:588–596. 2016. View Article : Google Scholar : PubMed/NCBI
2	Bostancıklıoğlu M: An update on the interactions between Alzheimer's disease, autophagy and inflammation. Gene. 705:157–166. 2019. View Article : Google Scholar : PubMed/NCBI
3	Jiang X, Overholtzer M and Thompson CB: Autophagy in cellular metabolism and cancer. J Clin Invest. 125:47–54. 2015. View Article : Google Scholar : PubMed/NCBI
4	White E: The role for autophagy in cancer. J Clin Invest. 125:42–46. 2015. View Article : Google Scholar : PubMed/NCBI
5	Levy JMM, Towers CG and Thorburn A: Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017. View Article : Google Scholar : PubMed/NCBI
6	Chude CI and Amaravadi RK: Targeting autophagy in cancer: Update on clinical trials and novel inhibitors. Int J Mol Sci. 18:12792017. View Article : Google Scholar
7	Zhou J, Li G, Zheng Y, Shen HM, Hu X, Ming QL, Huang C, Li P and Gao N: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy. 1:1259–1279. 2015. View Article : Google Scholar
8	Zhou J, Hu SE, Tan SH, Cao R, Chen Y, Xia D, Zhu X, Yang XF, Ong CN and Shen HM: Andrographolide sensitizes cisplatin-inducedapoptosis via suppression of autophagosome lysosome fusion in human cancer cells. Autophagy. 8:338–349. 2012. View Article : Google Scholar : PubMed/NCBI
9	Stamenkovic M, Janjetovic K, Paunovic V, Ciric D, Kravic-Stevovic T and Trajkovic V: Comparative analysis of cell death mechanisms induced by lysosomal autophagy inhibitors. Eur J Pharmacol. 859:1725402019. View Article : Google Scholar : PubMed/NCBI
10	Yang YY, Tang YZ, Fan CL, Luo HT, Guo PR and Chen JX: Identification and determination of the saikosaponins in Radix bupleuri by accelerated solvent extraction combined with rapid-resolution LC-MS. J Sep Sci. 33:1933–1945. 2010. View Article : Google Scholar : PubMed/NCBI
11	Tsuyoshi H, Wong VKW, Han Y, Orisaka M, Yoshida Y and Tsang BK: Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest. Oncotarget. 8:99825–99840. 2017. View Article : Google Scholar : PubMed/NCBI
12	Chen X, Liu C, Zhao R, Zhao P, Wu J, Zhou N and Ying M: Synergetic and antagonistic molecular effects mediated by the feedback loop of p53 and JNK between Saikosaponin D and SP600125 on lung cancer A549 cells. Mol Pharm. 15:4974–4984. 2018. View Article : Google Scholar : PubMed/NCBI
13	Chun YZ, Zhong MJ, Xiao FM, Yue L, Xiao ZL, Li LL, Wen HW and Tao W: Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia. Front Pharmacol. 10:1039–1052. 2019. View Article : Google Scholar : PubMed/NCBI
14	Li Y, Cai T, Zhang W, Zhu W and Lv S: Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells. Mol Med Rep. 16:1459–1464. 2017. View Article : Google Scholar : PubMed/NCBI
15	Wong VK, Li T, Law BY, Ma ED, Yip NC, Michelangeli F, Law CK, Zhang MM, Lam KY, Chan PL and Liu L: Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis. 4:e7202013. View Article : Google Scholar : PubMed/NCBI
16	Li C, Huang L, Sun W, Chen Y, He ML, Yue J and Ballard H: Saikosaponin D suppresses enterovirus A71 infection by inhibiting autophagy. Signal Transduct Target Ther. 4:42019. View Article : Google Scholar : PubMed/NCBI
17	Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
18	Yu RL, Yun JK, Myung HK and June MK: MAPK cascades in guard cell signal transduction. Front Plant Sci. 7:80–87. 2016.PubMed/NCBI
19	Mizushima N, Yoshimori T and Ohsumi Y: The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 27:107–132. 2011. View Article : Google Scholar : PubMed/NCBI
20	Katsuragi Y, Ichimura Y and Komatsu M: p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 282:4672–4678. 2015. View Article : Google Scholar : PubMed/NCBI
21	Kimura S, Noda T and Yoshimori T: Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 3:452–460. 2007. View Article : Google Scholar : PubMed/NCBI
22	Eskelinen EL: Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med. 27:495–502. 2006. View Article : Google Scholar : PubMed/NCBI
23	Siong Tan HW, Anjum B, Shen HM, Ghosh S, Yen PM and Sinha RA: Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels. Autophagy. 15:1455–1459. 2019. View Article : Google Scholar : PubMed/NCBI
24	Colacurcio DJ and Nixon RA: Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 32:75–88. 2016. View Article : Google Scholar : PubMed/NCBI
25	Woolbright BL, Ramachandran A, McGill MR, Yan HM, Bajt ML, Sharpe MR, Lemasters JJ and Jaeschke H: Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity. Basic Clin Pharmacol Toxicol. 111:417–425. 2012. View Article : Google Scholar : PubMed/NCBI
26	Miyagawa K, Oe S, Honma Y, Izumi H, Baba R and Harada M: Lipid-induced endoplasmic reticulum stress impairs selective autophagy at the step of autophagosome-lysosome fusion in hepatocytes. Am J Pathol. 186:1861–1873. 2016. View Article : Google Scholar : PubMed/NCBI
27	Ren M, McGowan E, Li Y, Zhu X, Lu X, Zhu Z, Lin Y and He S: Saikosaponin-d Suppresses COX2 through p-STAT3/C/EBPβ signaling pathway in liver cancer: A novel mechanism of action. Front Pharmacol. 10:6232019. View Article : Google Scholar : PubMed/NCBI
28	Gao T, Zhao P, Yu X, Cao S, Zhang B and Dai M: Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells. Am J Transl Res. 11:2070–2080. 2019.PubMed/NCBI
29	Li C, Guan X, Xue H, Wang P, Wang M and Gai X: Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Pathol Res Pract. 213:848–853. 2017. View Article : Google Scholar : PubMed/NCBI
30	Wang J, Qi H, Zhang X, Si W, Xu F, Hou T, Zhou H, Wang A, Li G, Liu Y, et al: Saikosaponin D from Radix bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling. Biomed Pharmacother. 108:724–733. 2018. View Article : Google Scholar : PubMed/NCBI
31	Cuadrado A and Nebreda AR: Mechanisms and functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010. View Article : Google Scholar : PubMed/NCBI
32	Chen W, Tan Y and Zhang Y: p38 MAPK signaling pathway activation by phenyl benzoxime in SNU-306 cells causes induction of apoptosis. Microb Pathog. 126:74–78. 2019. View Article : Google Scholar : PubMed/NCBI
33	Zhou Q, Wu X, Wen C, Wang H, Wang H, Liu H and Peng J: Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells. Biochem Biophys Res Commun. 505:261–266. 2018. View Article : Google Scholar : PubMed/NCBI
34	Gewirtz DA: The challenge of developing autophagy inhibition as a therapeutic strategy. Cancer Res. 76:5610–5614. 2016. View Article : Google Scholar : PubMed/NCBI
35	Palmeira dos Santos C, Pereira GJ, Barbosa CM, Jurkiewicz A, Smaili SS and Bincoletto C: Comparative study of autophagy inhibition by 3MA and CQ on cytarabine-induced death of leukaemia cells. J Cancer Res Clin Oncol. 140:909–920. 2014. View Article : Google Scholar : PubMed/NCBI
36	Somya V and Ravi M: A reversible autophagy inhibitor blocks autophagosome-lysosome fusion by preventing Stx17 loading onto autophagosomes. Mol Biol Cell. 30:2283–2295. 2019. View Article : Google Scholar : PubMed/NCBI
37	Yu L, Wu WK, Gu C, Zhong D, Zhao X, Kong Y, Lin Q, Chan MT, Zhou Z and Liu S: Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 7:14693–14707. 2016. View Article : Google Scholar : PubMed/NCBI
38	Dong LL, Yang Y, Quan L and Jian JW: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol. 28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
39	Mauvezin C and Neufeld TP: Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 11:1437–1438. 2015. View Article : Google Scholar : PubMed/NCBI
40	Malicdan MC and Nishino I: Autophagy in lysosomal myopathies. Brain Pathol. 22:82–88. 2012. View Article : Google Scholar : PubMed/NCBI
41	Man SM and Kanneganti TD: Regulation of lysosomal dynamics and autophagy by CTSB/cathepsin B. Autophagy. 12:2504–2505. 2016. View Article : Google Scholar : PubMed/NCBI
42	Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, Coppes RP, Engedal N, Mari M and Reggiori F: Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 14:1435–1455. 2018. View Article : Google Scholar : PubMed/NCBI
43	Shimizu S, Yoshida T, Tsujioka M and Arakawa S: Autophagic cell death and cancer. Int J Mol Sci. 15:3145–3153. 2014. View Article : Google Scholar : PubMed/NCBI
44	Zhang H, Ge S, He K, Zhao X, Wu Y, Shao Y and Wu X: FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial-apoptosis in diabetes. Cardiovasc Res. 115:2008–2020. 2019. View Article : Google Scholar : PubMed/NCBI